ClinConnect ClinConnect Logo
Search / Trial NCT06585865

Strength Training and Resveratrol

Launched by TEXAS TECH UNIVERSITY · Sep 3, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Resistance Training Aging Resveratrol Sarcopenia Extracellular Vesicles Micro Rn As

ClinConnect Summary

This clinical trial, titled "Strength Training and Resveratrol," is exploring whether a supplement called resveratrol can help older adults (aged 60 and above) get stronger when they do strength training exercises. The study aims to see if taking resveratrol can enhance muscle growth and also improve blood vessel and brain function during and after exercising. Researchers will look at how resveratrol affects tiny particles in the body that help communicate between organs, as this might shed light on how the body responds to strength training.

To join the study, participants must be at least 60 years old, not very active (doing less than one hour of structured exercise each week besides walking), and have not done any strength training in the last six months. They should also not be taking resveratrol supplements currently. The study is not open for recruitment yet, but once it starts, participants can expect to engage in strength training sessions and take the resveratrol supplement, while being monitored for their overall health and progress. It's important for potential participants to be in stable health, without serious medical conditions that could make exercise risky, and to avoid certain substances like cannabis or excessive alcohol.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 60+
  • Minimally active (less than 1 hour of structured exercise/week other than walking)
  • No resistance training for the previous 6 months
  • Not currently taking resveratrol supplements
  • Stable medication, supplement, dietary, and physical activity regimens for the previous 3 months and no plans to change throughout the study period
  • Body mass at least 110 lbs
  • Exclusion Criteria:
  • Medical complications that could increase risk during exercise (e.g., cardiovascular disease, uncontrolled hypertension, type 1 or 2 diabetes, orthopedic contraindication to exercise, kidney disease, etc.)
  • Cannabis or nicotine use
  • Consume more than 7 alcohol-containing beverages per week

About Texas Tech University

Texas Tech University, a distinguished research institution located in Lubbock, Texas, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a focus on multidisciplinary collaboration and rigorous scientific methodology, Texas Tech University conducts a variety of studies aimed at exploring new treatments, enhancing health outcomes, and addressing pressing healthcare challenges. The university's experienced faculty and state-of-the-art facilities ensure high standards of research integrity and participant safety, making it a trusted sponsor in the field of clinical research.

Locations

Lubbock, Texas, United States

Patients applied

0 patients applied

Trial Officials

Danielle E Levitt, PhD

Principal Investigator

Texas Tech University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported